Jesta Group
  • Home
  • About Us
  • Property Portfolio
  • Press
  • Contact
  • FR
Select Page
Jesta Group is proud to invest in Curesponse’s innovative cancer treatment technology.

Jesta Group is proud to invest in Curesponse’s innovative cancer treatment technology.

by Eric Valois | Sep 14, 2020 | Uncategorized

Jesta Group is a proud investor in cResponse, an innovative cancer treatment technology designed by Curesponse in collaboration with the Weizmann Institute of Science, in order to provide a more personalized and efficient treatment of the disease. cResponse takes a...

Archives

  • January 2022
  • September 2020
  • April 2020

Categories

  • Uncategorized

Recent posts

  • Allied paying $250M to buy office portion of Montreal’s Gare Viger
  • Jesta Group is proud to invest in Curesponse’s innovative cancer treatment technology.
  • Jesta Group Sells Berlin Nhow Hotel Property Amid Pandemic

Jesta Group

  • Canada

    755 Berri, suite 200
    Montreal, Qc
    H2Y 3E5

    +1 514 925 5100

  • United Kingdom

    29 Davies Street
    Suite B
    London W1K 5JT


    +44 207 659 0390

  • France

    9 Rue Lincoln, 3ième étage
    75008, Paris


    +33 1 44 43 83 83

JESTA I.S.

Linkedin
© Copyright 2023 -Chelsey Investissement S.C.A. - All rights reserved.
NTD: Some properties may no longer form part of our portfolio.